- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
Oramed Pharmaceuticals Inc
+ Add to WatchlistORMP:US
9.7100 USD 0.4900 4.80%As of 13:05:35 ET on 05/22/2013.
Snapshot for Oramed Pharmaceuticals Inc (ORMP)
| Open: | 10.0000 | Day's Range: | 9.6100 - 10.3500 | Volume: | 82,741 |
|---|---|---|---|---|---|
| Previous Close: | 10.2000 | 52wk Range: | 2.7600 - 10.6775 | 1-Yr Rtn: | +151.82% |
Key Statistics for ORMP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.6500 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 73.67 |
| Shares Outstanding (M) | 7.22 |
| 30 Day Average Volume | 44,760 |
| Price/Book (mrq) | 13.3085 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/12/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ORMP
No data available
Company Profile & Key Executives for ORMP
Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.
| Nadav KidronPresident/CEO | Yifat ZommerCFO/Treasurer/Secretary |
| Miriam KidronCTO/Chief Medical Ofcr | Joshua Hexter "Josh"VP:Business Dev/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ORMP News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page